Transfusion of patients undergoing bone marrow transplantation

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Bone marrow transplant recipients require intensive transfusion support preceding the marrow infusion, because of their underlying disease or the chemotherapeutic agents administered, and for 14 days or more post-transplantation until engraftment has occurred and marrow function has returned. Red blood cells, plasma, and platelets are the usual components transfused; granulocyte concentrates are occasionally required. Marrow transplantation across ABO and Rh barriers is performed routinely and requires careful, knowledgeable attention to the blood group of components chosen throughout the transplantation process to ensure effective transfusion support. This paper is a review of the general principles governing pre- and post-transplantation transfusion support, potential indications for the transfusion of various blood components in the marrow transplant setting, and the recommended blood groups of these components when ABO incompatibilities exist.

Original languageEnglish (US)
Pages (from-to)261-266
Number of pages6
JournalHuman Pathology
Volume14
Issue number3
DOIs
StatePublished - Mar 1983

Fingerprint

Bone Marrow Transplantation
Transplantation
Bone Marrow
Blood Group Antigens
Blood Component Transfusion
Granulocytes
Blood Platelets
Erythrocytes
Transplants

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Transfusion of patients undergoing bone marrow transplantation. / Warkentin, Phyllis I.

In: Human Pathology, Vol. 14, No. 3, 03.1983, p. 261-266.

Research output: Contribution to journalArticle

@article{226287d3f6714d54a175242bed597fac,
title = "Transfusion of patients undergoing bone marrow transplantation",
abstract = "Bone marrow transplant recipients require intensive transfusion support preceding the marrow infusion, because of their underlying disease or the chemotherapeutic agents administered, and for 14 days or more post-transplantation until engraftment has occurred and marrow function has returned. Red blood cells, plasma, and platelets are the usual components transfused; granulocyte concentrates are occasionally required. Marrow transplantation across ABO and Rh barriers is performed routinely and requires careful, knowledgeable attention to the blood group of components chosen throughout the transplantation process to ensure effective transfusion support. This paper is a review of the general principles governing pre- and post-transplantation transfusion support, potential indications for the transfusion of various blood components in the marrow transplant setting, and the recommended blood groups of these components when ABO incompatibilities exist.",
author = "Warkentin, {Phyllis I.}",
year = "1983",
month = "3",
doi = "10.1016/S0046-8177(83)80028-8",
language = "English (US)",
volume = "14",
pages = "261--266",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Transfusion of patients undergoing bone marrow transplantation

AU - Warkentin, Phyllis I.

PY - 1983/3

Y1 - 1983/3

N2 - Bone marrow transplant recipients require intensive transfusion support preceding the marrow infusion, because of their underlying disease or the chemotherapeutic agents administered, and for 14 days or more post-transplantation until engraftment has occurred and marrow function has returned. Red blood cells, plasma, and platelets are the usual components transfused; granulocyte concentrates are occasionally required. Marrow transplantation across ABO and Rh barriers is performed routinely and requires careful, knowledgeable attention to the blood group of components chosen throughout the transplantation process to ensure effective transfusion support. This paper is a review of the general principles governing pre- and post-transplantation transfusion support, potential indications for the transfusion of various blood components in the marrow transplant setting, and the recommended blood groups of these components when ABO incompatibilities exist.

AB - Bone marrow transplant recipients require intensive transfusion support preceding the marrow infusion, because of their underlying disease or the chemotherapeutic agents administered, and for 14 days or more post-transplantation until engraftment has occurred and marrow function has returned. Red blood cells, plasma, and platelets are the usual components transfused; granulocyte concentrates are occasionally required. Marrow transplantation across ABO and Rh barriers is performed routinely and requires careful, knowledgeable attention to the blood group of components chosen throughout the transplantation process to ensure effective transfusion support. This paper is a review of the general principles governing pre- and post-transplantation transfusion support, potential indications for the transfusion of various blood components in the marrow transplant setting, and the recommended blood groups of these components when ABO incompatibilities exist.

UR - http://www.scopus.com/inward/record.url?scp=0020522301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020522301&partnerID=8YFLogxK

U2 - 10.1016/S0046-8177(83)80028-8

DO - 10.1016/S0046-8177(83)80028-8

M3 - Article

C2 - 6403451

AN - SCOPUS:0020522301

VL - 14

SP - 261

EP - 266

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 3

ER -